Blood Transfusion Diagnostics Market Forecast 2023-2027 By The Business Research Company
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
The Business Research Company’s blood transfusion diagnostics market report forecasts the blood transfusion diagnostics market size to grow to $5.68 Billion by 2027, with a CAGR (compound annual growth rate) of more than 9%.
Learn More On The Blood Transfusion Diagnostics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report
Blood Transfusion Diagnostics Market Size Forecast
The global blood transfusion diagnostics market is expected to grow from $3.65 billion in 2022 to $3.98 billion in 2023 at a compound annual growth rate (CAGR) of 9.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The blood transfusion diagnostics market is expected to grow from $5.68 billion in 2027 at a CAGR of 9.3%.
North America held the largest blood transfusion diagnostics market share.
Key Blood Transfusion Diagnostics Market Driver – Increase In The Number Of Procedures
According to an article published in the US National Library of Medicine, National Institutes of Health, approximately 310 million surgeries are being performed each year. This increase in the number of procedures will thereby drive the need for blood transfusion diagnostics.
Request for A Sample Of The Global Blood Transfusion Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2494&type=smp
Key Blood Transfusion Diagnostics Market Trend – Growing Demand For Advanced Diagnostic Measures
The growing demand for advanced diagnostic measures and growing prevalence of infectious diseases associated with pathogens such as bacteria & viruses increase the preference for nucleic acid amplification testing (NAAT/NAT) to increase blood safety, improve efficiency and reduce the turnaround time of the results. NAT is a technique that helps detect a particular nucleic acid, virus, or bacteria that acts as a pathogen in blood, tissue, or urine. NAT is highly sensitive and specific for viral nucleic acids and amplifies the region of targeted viral DNA and detects them earlier than the other traditional methods and narrows the period of infectious diseases. For example, XCRP Diagnostic Inc. and Luminex Corporations entered into a licensing agreement of XCR Diagnostic’s Xtreme Chain Reaction Nucleic Acid Amplification Technology. In this deal, Luminex got the exclusive rights to use the XCR Diagnostic’s NAAT technology for their future molecular diagnostic portfolio.
Blood Transfusion Diagnostics Market Segment
1) By Type: Instruments and Kits, Reagents, Other Types
2) By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies
3) By Technology: Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test
4) By Application: Blood Grouping, Disease Screening
Blood Transfusion Diagnostics Market Major Players and Strategies
Major players in the blood transfusion diagnostics market are BAG Health Care GmbH, Grifols, Bio-Rad Laboratories Inc., Abbott Laboratories, Immucor Inc., Ortho Clinical Diagnostics, DiaSorin S.p.A, Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc., and Beckman Coulter Inc.
The Blood Transfusion Diagnostics Global Market Report 2023 covers regional data on blood transfusion diagnostics market size, blood transfusion diagnostics market trends and drivers, opportunities, strategies, and blood transfusion diagnostics market competitor analysis. The countries covered in the blood transfusion diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
Blood transfusion diagnostics are used to conduct tests before the transfusion of blood from donor-recipient such as blood grouping disease screening.
View More Reports Related To The Blood Transfusion Diagnostics Market –
Blood And Blood Components Global Market Report 2022
Blood Group Typing Global Market Report 2022
Blood Collection Devices Global Market Report 2022
Email us at [email protected]
Call us at:
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Follow us on:
LinkedIn: https://bit.ly/3WzV8lZ
YouTube: https://bit.ly/3jiemhz
Global Market Model: https://bit.ly/3Was30B